InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 [Yahoo! Finance]
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $5.00 price target on the stock.
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) [Yahoo! Finance]